These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 4342829)
1. Positive contrast ventriculography--a comparison between Conray (methylglucamine lothalamate 60 per cent) and Pantopaque (di-iodophenyl undecylate). Siqueira EB; Arumugasamy N Neurochirurgia (Stuttg); 1972 Sep; 15(5):173-7. PubMed ID: 4342829 [No Abstract] [Full Text] [Related]
2. A study of acid-base balance of CSF in connection with positive ventriculography using water soluble contrast media (Conray). Tanji H; Takahashi M; Masu K; Kawaguchi Y; Abe H Fukushima J Med Sci; 1976 Mar; 22(1-2):49-63. PubMed ID: 1088413 [No Abstract] [Full Text] [Related]
3. The hazards of myelography. Peterson HO Radiology; 1975 Apr; 115(1):237-9. PubMed ID: 164045 [TBL] [Abstract][Full Text] [Related]
6. [Severe reactions caused by Conray-400 used in ventriculography and myelography]. Li ZX Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1982 Sep; 15(3):141-2. PubMed ID: 6983954 [No Abstract] [Full Text] [Related]
7. Positive contrast ventriculography: a comparison between methyglucamine iothalamate sixty per cent and diiodeophenyl undecylate. Siqueira EB; Arumugasamy N Surg Forum; 1970; 21():441-2. PubMed ID: 5315225 [No Abstract] [Full Text] [Related]
8. [Roentgen appearance of the normal fourth ventricle in positive contrast ventriculography (pantopaque and conray) (author's transl)]. Li GX Zhonghua Fang She Xue Za Zhi; 1981 Aug; 15(3):207-8. PubMed ID: 6461527 [No Abstract] [Full Text] [Related]
10. Seizures associated with the use of meglumine iothalamate 60 per cent in ventriculography. Picaza JA; Hunter SE; Lee L J Neurosurg; 1972 Apr; 36(4):474-80. PubMed ID: 4536861 [No Abstract] [Full Text] [Related]
11. [Contrast media in use in myelography and ventriculography: current status and future prospects]. Gonsette RE Radiol Med; 1980 Apr; 66(4):195-202. PubMed ID: 6256823 [No Abstract] [Full Text] [Related]
12. [Clinical experience in conray ventriculography]. Sakamoto S; Shirao T; Okuma Y; Ando M Rinsho Hoshasen; 1971 Oct; 16(10):863-8. PubMed ID: 5316976 [No Abstract] [Full Text] [Related]
13. A clinical and experimental study of meglumine iocarmate in the subarachnoid space: a complication of positive contrast ventriculography. Yonekawa Y; Nishikawa M; Egli M; Klaiber R Surg Neurol; 1976 Mar; 5(3):167-70. PubMed ID: 816023 [TBL] [Abstract][Full Text] [Related]
14. [Urography with Iodomiron--a clinical comparison with Conray 400]. Idbohrn H; Movin A Lakartidningen; 1973 Jan; 70(4):283-4. PubMed ID: 4683679 [No Abstract] [Full Text] [Related]
15. Experiences with the technique and complications of meglumine iothalamate (Conray) ventriculography. Natelson SE; Sayers MP; Hunt WE J Neurol Neurosurg Psychiatry; 1972 Apr; 35(2):264-9. PubMed ID: 4537662 [TBL] [Abstract][Full Text] [Related]
16. Pulmonary oil embolization following Pantopaque ventriculography in a patient with a ventriculovenous shunt. Case report. Allen WE; D'Angelo CM J Neurosurg; 1971 Nov; 35(5):623-7. PubMed ID: 5315821 [No Abstract] [Full Text] [Related]
17. [Use of water-soluble contrast preparations for myelography (review of the forign literature)]. Sviridov NK Vopr Neirokhir; 1971; 35(3):56-9. PubMed ID: 5002830 [No Abstract] [Full Text] [Related]
18. [Note on toxicology of water-soluble iodized contrast media]. Magno L Minerva Radiol; 1966 Dec; 11(12):683-6. PubMed ID: 5997847 [No Abstract] [Full Text] [Related]